1248 Ltd, whose technology targets the multi billion dollar Internet of Things industry, launched with a mighty endorsement – a £250,000 investment from experienced serial telco entrepreneur Rob Dobson.
Cambridge Science Park company, Abcam spun out of Cambridge University and has since become a world leader.
Biopharmaceuticals are an increasingly important class of medicines with over 400 products estimated to be in clinical development and the market expected to increase from $199.7 billion in 2013 to $497.9 billion by 2020.
AlertMe is a leading technology innovator in cloud-based Smart Home Services. It helps partners deliver the benefits of the Smart Grid and Smart Home to consumers.
Amino Communications is a world leading IPTV and hybrid/OTT innovator – bringing new entertainment products and solutions to a global market.
ARM is the world's leading semiconductor intellectual property (IP) supplier and is at the heart of the development of digital electronic products.
AVEVA, quoted on London’s main market, has been the world's leading engineering software provider to the plant, power and marine industries for more than 40 years.
Axol Bioscience is an exciting biotech company co-founded and co-funded privately by Abcam CEO, Dr Jonathan Milner, and Dr Yichen Shito to fulfil the unmet demand for high quality iPS cell-derived, clinically relevant cells for use in biomedical research and discovery.
Eight19 spin-out, Azuri brings power at scale to off-grid customers in rural emerging markets, providing basic needs that are regarded as routine in more developed countries.
Bango provides the technology that powers commerce for businesses targeting the growing market of internet enabled mobile phone users.
BIOVIA bounces into The Killer50 following the acquisition of Accelrys in Cambridge by Dassault Systèmes.
BlueGnome was founded in Cambridge in 2002 by a team of scientists who developed a novel mathematical technology for the analysis of genetic data following the sequencing of the human genome in 2000.
Software security startup Bromium, with operations in Cambridge and California, roared out of stealth mid-June 2012 with a $26.5 million Series B round.
CCS is a spin-out from Cambridge University exploiting innovative patented technology, jointly developed in collaboration with the University of Warwick, in the area of CMOS micro-systems.
Cambridge Cognition is the leading provider of cognitive assessment software for academic research, healthcare provision and clinical trials. Its cognitive assessment software, powered by Cantab technology, has been highly validated by over 1,200 peer-review publications.
Cambridge Consultants arguably founded the Cambridge technology cluster in 1960 when Tim Eiloart, while studying at Trinity College, amassed £400 to start an enterprise to “put the brains of Cambridge University at the disposal of the problems of British industry.”
Page 1 of 4